By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

PTC Therapeutics, Inc. 

100 Corporate Court

South Plainfield  New Jersey  07080-2449  U.S.A.
Phone: 908-222-7000 Fax: 908-222-7231


SEARCH JOBS



Segment
Drug Discovery





Company News
PTC Therapeutics, Inc. (PTCT) Announces Expanded Access Program For Translarna™ (ataluren) 7/9/2014 8:44:56 AM
PTC Therapeutics, Inc. (PTCT) Recipient Of Parent Project Muscular Dystrophy's "Path To Progress" Award 6/30/2014 8:59:56 AM
PTC Therapeutics, Inc. (PTCT) Initiates Confirmatory Phase 3 Clinical Trial Of Translarna™ (Ataluren) In Patients With Nonsense Mutation Cystic Fibrosis (nmCF) 6/30/2014 8:49:28 AM
PTC Therapeutics, Inc. (PTCT) To Present At The 9th Annual JMP Securities Healthcare Conference 6/17/2014 10:13:48 AM
PTC Therapeutics, Inc. (PTCT) Release: Shane Kovacs Receives The 2014 New Jersey Technology Council CFO - Deal Of The Year Award 6/13/2014 7:07:17 AM
PTC Therapeutics, Inc. (PTCT) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 6/11/2014 9:22:42 AM
PTC Therapeutics, Inc. (PTCT) Appoints Ronald C. Renaud, Jr. To Board Of Directors 6/11/2014 6:53:08 AM
EU Changes Its Tune On PTC Therapeutics, Inc. (PTCT) Drug, Shares Rocket 30.74% At Market Close (May 23, 2014) 5/23/2014 6:58:44 AM
PTC Therapeutics, Inc. (PTCT) To Present At The Jefferies and Co. 2014 Global Healthcare Conference 5/22/2014 6:38:37 AM
PTC Therapeutics, Inc. (PTCT) Release: Ataluren Phase 3 Trial Results In Nonsense Mutation Cystic Fibrosis Published In The Lancet Respiratory Medicine 5/16/2014 9:13:05 AM
12345678910...
//-->